Literature DB >> 10521432

Nuclear DEAF-1-related (NUDR) protein contains a novel DNA binding domain and represses transcription of the heterogeneous nuclear ribonucleoprotein A2/B1 promoter.

R J Michelson1, M W Collard, A J Ziemba, J Persinger, B Bartholomew, J I Huggenvik.   

Abstract

Nuclear DEAF-1-related (NUDR) protein is a novel transcriptional regulator with sequence similarity to developmental and oncogenic proteins. NUDR protein deletions were used to localize the DNA binding domain between amino acids 167 and 368, and site-specific DNA photocross-linking indicated at least two sites of protein-DNA contact within this domain. The DNA binding domain contains a proline-rich region and a region with similarity to a Myc-type helix-loop-helix domain but does not include the zinc finger motif at the C terminus. Deoxyribonuclease I protection assays confirmed the presence of multiple NUDR binding motifs (TTC(C/G)G) in the heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) promoter and also in the 5'-untranslated region (UTR) of hNUDR cDNA. NUDR produced a 65-70% repression of the hnRNP A2/B1 promoter activity, and NUDR binding motifs in the 5'-UTR were found to mediate this repression. NUDR-dependent repression was also observed when the 5'-UTR of NUDR was placed onto a heterologous thymidine kinase promoter in an analogous 5'-UTR position but not when placed upstream of transcription initiation. These results suggest that NUDR may regulate the in vivo expression of hnRNP A2/B1 and NUDR genes and imply that inactivation of NUDR could contribute to the overexpression of hnRNP A2/B1 observed in some human cancers.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521432     DOI: 10.1074/jbc.274.43.30510

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism.

Authors:  Rainer J Egli; Lorraine Southam; James M Wilkins; Inken Lorenzen; Manuel Pombo-Suarez; Antonio Gonzalez; Andrew Carr; Kay Chapman; John Loughlin
Journal:  Arthritis Rheum       Date:  2009-07

2.  Functional analysis of novel DEAF1 variants identified through clinical exome sequencing expands DEAF1-associated neurodevelopmental disorder (DAND) phenotype.

Authors:  Li Chen; Philip J Jensik; Joseph T Alaimo; Magdalena Walkiewicz; Seth Berger; Elizabeth Roeder; Eissa A Faqeih; Jonathan A Bernstein; Ann C M Smith; Sureni V Mullegama; David W Saffen; Sarah H Elsea
Journal:  Hum Mutat       Date:  2017-09-23       Impact factor: 4.878

3.  Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire.

Authors:  Maureen A Su; Karen Giang; Kristina Zumer; Huimin Jiang; Irena Oven; John L Rinn; Jason J Devoss; Kellsey P A Johannes; Wen Lu; James Gardner; Angela Chang; Paula Bubulya; Howard Y Chang; B Matija Peterlin; Mark S Anderson
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

4.  Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3.

Authors:  Linda Yip; Remi J Creusot; Cara T Pager; Peter Sarnow; C Garrison Fathman
Journal:  J Mol Cell Biol       Date:  2012-08-24       Impact factor: 6.216

5.  Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems.

Authors:  Anneke T Vulto-van Silfhout; Shivakumar Rajamanickam; Philip J Jensik; Sarah Vergult; Nina de Rocker; Kathryn J Newhall; Ramya Raghavan; Sara N Reardon; Kelsey Jarrett; Tara McIntyre; Joseph Bulinski; Stacy L Ownby; Jodi I Huggenvik; G Stanley McKnight; Gregory M Rose; Xiang Cai; Andy Willaert; Christiane Zweier; Sabine Endele; Joep de Ligt; Bregje W M van Bon; Dorien Lugtenberg; Petra F de Vries; Joris A Veltman; Hans van Bokhoven; Han G Brunner; Anita Rauch; Arjan P M de Brouwer; Gemma L Carvill; Alexander Hoischen; Heather C Mefford; Evan E Eichler; Lisenka E L M Vissers; Björn Menten; Michael W Collard; Bert B A de Vries
Journal:  Am J Hum Genet       Date:  2014-04-10       Impact factor: 11.025

6.  Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism.

Authors:  Margaret Czesak; Sylvie Lemonde; Erica A Peterson; Anastasia Rogaeva; Paul R Albert
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

7.  DEAF-1 regulates immunity gene expression in Drosophila.

Authors:  Darien E Reed; Xinhua M Huang; James A Wohlschlegel; Michael S Levine; Kate Senger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

8.  Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4.

Authors:  Liza Cubeddu; Soumya Joseph; Derek J Richard; Jacqueline M Matthews
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 9.  Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.

Authors:  Paul R Albert; Brice Le François; Anne M Millar
Journal:  Mol Brain       Date:  2011-05-27       Impact factor: 4.041

10.  Structural and functional analysis of the DEAF-1 and BS69 MYND domains.

Authors:  Fatiha Kateb; Helene Perrin; Konstantinos Tripsianes; Peijian Zou; Roberta Spadaccini; Matthew Bottomley; Titus M Franzmann; Johannes Buchner; Stephane Ansieau; Michael Sattler
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.